Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
04/29/2010 | US20100105620 Polypeptides that bind Trail-R1 and Trail-R2 |
04/29/2010 | US20100105576 Three Frame cDNA Expression Libraries for Functional Screening of Proteins |
04/29/2010 | US20100105565 Evolved Orthogonal Ribosomes |
04/29/2010 | US20100105141 Sulfonylurea-Responsive Repressor Proteins |
04/29/2010 | US20100105140 Plaice dna transposon system |
04/29/2010 | US20100105136 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors |
04/29/2010 | US20100105134 Nucleic acid compounds for inhibiting gene expression and uses thereof |
04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
04/29/2010 | US20100105120 Photocleavable sense-antisense complex |
04/29/2010 | US20100105117 Gene associated with foam formation of acetic acid bacterium, acetic acid bacterium bred by modifying the gene and method for producing vinegar using the acetic acid bacterium |
04/29/2010 | US20100105090 Secreted luciferase mluc7 and use thereof |
04/29/2010 | US20100105088 method for diagnosing atherosclerotic plaques by measurement of cd36 |
04/29/2010 | US20100105064 Method of screening test substances for treating or preventing a disease mediated by plasma cells |
04/29/2010 | US20100105059 Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis pmpa gene |
04/29/2010 | US20100105051 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
04/29/2010 | US20100105047 Method for the Simultaneous Determination of Blood Group and Platelet Antigen Genotypes |
04/29/2010 | US20100105041 Reagents and methods for detecting cyp2d6 polymorphisms |
04/29/2010 | US20100105028 Probe for detecting nucleic acids |
04/29/2010 | US20100104690 Tagged Microorganisms and Methods of Tagging |
04/29/2010 | US20100104607 Anti-bacterial peptides and methods of treating diseases using same |
04/29/2010 | US20100104606 Allergen fragments |
04/29/2010 | US20100104598 Development of dengue virus vaccine components |
04/29/2010 | US20100104597 N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
04/29/2010 | US20100104591 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
04/29/2010 | US20100104578 Method and composition for treatment of neoplasms |
04/29/2010 | US20100104577 Methods and materials related to anti-a (beta) antibodies |
04/29/2010 | US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
04/29/2010 | US20100104573 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
04/29/2010 | US20100104568 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
04/29/2010 | US20100104560 Botulinum neurotoxin e receptors and uses thereof |
04/29/2010 | US20100104556 Epitope-tag for surface-expressed proteins and uses thereof |
04/29/2010 | US20100104555 HCV neutralizing epitopes |
04/29/2010 | US20100104550 Cleavage of bip by subtilase cytotoxin |
04/29/2010 | US20100104531 Homogeneous preparations of il-28 and il-29 |
04/29/2010 | US20100104530 Anti-vpac1 antibodies and their uses |
04/29/2010 | US20100104529 TNF-alpha VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-alpha |
04/29/2010 | US20100104508 Human antibodies that bind cxcr4 and uses thereof |
04/29/2010 | CA2750054A1 Transposon end compositions and methods for modifying nucleic acids |
04/29/2010 | CA2741294A1 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom |
04/29/2010 | CA2741204A1 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
04/29/2010 | CA2740913A1 Improved allele-specific amplification |
04/29/2010 | CA2739895A1 Compositions and methods for inhibiting expression of transthyretin |
04/28/2010 | EP2180309A2 Method and apparatus for synthesis of arrays of DNA probes |
04/28/2010 | EP2180064A2 Multiplex quantification of nucleic acids in diseased cells |
04/28/2010 | EP2180049A1 Devices and compositions for lysis of occlusive blood clots while sparing wound sealing clots comprising a mutant pro-urokinase |
04/28/2010 | EP2180044A1 Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity |
04/28/2010 | EP2180007A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
04/28/2010 | EP2180006A2 Labeled compound and detection method using the same |
04/28/2010 | EP2179996A1 Sulfonated diarylrhodamine dyes |
04/28/2010 | EP2178897A1 Nucleic acid sequences for the amplification and detection of respiratory viruses |
04/28/2010 | EP2178896A1 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
04/28/2010 | EP2178567A2 Stabilized immune modulatory rna (simra) compounds |
04/28/2010 | EP1694692B1 Formulations and methods for denaturing proteins |
04/28/2010 | EP1673450B1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
04/28/2010 | EP1592799B1 Annexin promoter and use in expression of transgenic genes in plants |
04/28/2010 | EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi) |
04/28/2010 | EP1363640B1 Nucleic acid derivatives |
04/28/2010 | EP1080228B1 In situ hybridization method for detecting target nucleic acid |
04/28/2010 | CN1875117B Real-time detection of nucleic acids and proteins |
04/28/2010 | CN1813066B Novel beta-actin and rps21 promoters and uses thereof |
04/28/2010 | CN1768074B A diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
04/28/2010 | CN1703426B Humanized antibodies that recognize beta amyloid peptide |
04/28/2010 | CN1611509B Nucleic acid adaptor for specific identifying human cerebral acetylcholinesterase and its use |
04/28/2010 | CN1487080B Alkaline protease |
04/27/2010 | US7705222 methods, compositions and apparatus for detection, identification and/or sequencing of nucleic acids and/or other biomolecules using nano-barcodes and scanning probe microscopy; high speed of obtaining sequence data, low cost of sequencing, high efficiency in terms of amount of operator time required |
04/27/2010 | US7705221 Plants and seeds of corn variety CV237850 |
04/27/2010 | US7705202 Expression vector comprising nucleotide sequences coding fatty acid synthases for enhancing synthesis of docosahexanoic acid cells; increasing nutrient quality of crop plants |
04/27/2010 | US7705141 novel human genes RNF43 whose expression is markedly elevated in colorectal cancers; genes and polypeptides encoded by the genes can be used in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease |
04/27/2010 | US7705140 DNAs encoding TNF receptor family members |
04/27/2010 | US7705137 Nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; detergents; leather; food; dairyproducts; drugs; cheeses; tanning; cost efficiency; industrial scale |
04/27/2010 | US7705136 preparing a biochip by placing a mixture comprising an oligonucleotide and gel forming monomers comprising acrylamide or/and methacrylamide on a solid support and polymerizing the mixture |
04/27/2010 | US7705133 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders; hybridoma cell line; radioimmunoassay; kits |
04/27/2010 | US7705126 Compositions for controlling hair growth |
04/27/2010 | US7705120 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
04/27/2010 | US7705119 A Deltorphin-E polypeptide having a specific amino acid sequence and acarrier; antishock agents; opiod receptor agonists; nucleotide sequence;hypertensive agents; antiinflammatory agents; antiischemic agents; surgery;restoring perfusion to organs and tissues; prophylaxis |
04/27/2010 | US7704969 Transfection complexes |
04/27/2010 | US7704968 treating cancer with antisense oligonucleotide complementary to a region of a nuclear factor- kappa B(NF- kappa B) subunit mRNA, contains phosphate backbone chemically modified; leukemia, fibroblast cancer; inhibiting septic shock; biocompatibility with no side effect |
04/27/2010 | US7704967 TFIIS and GDOWN1 as targets for cancer therapy |
04/27/2010 | US7704965 Methods and materials for treating human papillomavirus infections |
04/27/2010 | US7704963 Administering as antitumor or anticarcinogenic agent; interference RNA |
04/27/2010 | US7704962 Small oligonucleotides with anti-tumor activity |
04/27/2010 | US7704925 Ligational encoding using building block oligonucleotides |
04/27/2010 | US7704719 genetic and protein engineered thermoanaerobacterium saccharolyticum glucose isomerase, provides a series of glucose isomerases with improved thermostability catalytic activity suitable for the production of high fructose corn syrup containing high concentration of fructose |
04/27/2010 | US7704717 Plant caffeic acid-3-O-methyltransferase homologs |
04/27/2010 | US7704716 Geraniol synthase, methods of production and uses thereof |
04/27/2010 | US7704715 Polymorphic monooxygenase comprising mutation in heme domain of a secondary structural element and enhanced heat stability; improved peroxide-driven hydroxylation |
04/27/2010 | US7704711 Human protein kinases and uses therefor |
04/27/2010 | US7704698 Human T2R51 taste receptor and related assays for identifying bitter taste modulators |
04/27/2010 | US7704691 assessing sample for presence of mutation of interest in senataxin (SETX) gene, wherein mutation is 4 base deletion of nucleotides 369-372, detecting deletion of nucleotides 369-372 wherein presence of mutation is indicative of presence of genetic polymorphism associated with ataxia-ocular apraxia 2 |
04/27/2010 | US7704688 Using RNA interference to prevent and treat viral diseases |
04/27/2010 | US7704685 In vivo production of a clostridial neurotoxin light chain peptide |
04/27/2010 | US7704513 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
04/27/2010 | US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
04/27/2010 | CA2387306C Assays for short sequence variants |
04/27/2010 | CA2374377C Potassium channel kcnq5 |
04/27/2010 | CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis |
04/27/2010 | CA2324978C Method, reagent and kit for genotyping of human papillomavirus |
04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
04/27/2010 | CA2289907C Eukaryotic and retroviral antisense initiator elements |
04/27/2010 | CA2278465C Diagnosis and treatment of myocardial failure |